Novabridge Biosciences ADR
(NBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 12-2019 | 12-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 435,963 | 171,405 | N/A |
| Marketable Securities | 4,201 | 4,597 | N/A |
| Other current assets | 32,379 | 19,540 | 0 |
| TOTAL | $472,543 | $195,542 | $N/A |
| Non-Current Assets | |||
| Other Non-Current Assets | 0 | 47,365 | 0 |
| TOTAL | $N/A | $47,365 | $N/A |
| Total Assets | $633,037 | $249,587 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | 7,182 | N/A |
| Other current liabilities | N/A | 39,293 | N/A |
| TOTAL | $51,460 | $47,453 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 9,796 | 0 |
| TOTAL | $N/A | $10,359 | $N/A |
| Total Liabilities | $81,954 | $58,888 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | N/A | N/A | 57,664 |
| Common Shares | N/A | 11 | N/A |
| Retained earnings | -451,403 | -358,270 | N/A |
| Other shareholders' equity | 1,002,486 | 10,074 | 0 |
| TOTAL | $551,083 | $190,699 | $N/A |
| Total Liabilities And Equity | $633,037 | $249,587 | $0 |